Investment
Features
FeesSafety
Academy
More
Pluang+

Treasury bills offer higher fixed yields than Johnson & Johnson dividends, but tax and risk factors affect retirement income choice.

Market News
12 Oct 2026
24/7 Wall Street
View Source
Bullish
Treasury bills offer higher fixed yields than Johnson & Johnson dividends, but tax and risk factors affect retirement income choice.

As of October 2026, U.S. Treasury bills yield between 3.98% and 4.44% depending on maturity, surpassing Johnson & Johnson's 2.05% dividend yield. Treasury bills guarantee fixed returns until maturity but carry reinvestment and inflation risks, while J&J's dividend can grow but may be cut by the board. Tax treatment varies: Treasury interest is exempt from state taxes but taxed as ordinary income federally, whereas J&J dividends benefit from lower federal capital gains rates but are subject to state taxes. Retirees may prefer Treasury bills for short-term, stable income especially in high-tax states, while dividend stocks suit those seeking income growth and can tolerate price fluctuations. Many balance both for certainty and growth in retirement portfolios.

As of Oct 12, 2026 19:31 WIB, Johnson & Johnson (JNJ) shares trade at USD 261.59 with a slight 1-day increase of 0.06% on Pluang. The stock offers a dividend yield of 2.05%, which is notably lower than current U.S. Treasury bill yields cited in the article. JNJ's market capitalization stands at $630.04 billion, reflecting its substantial presence in the health sector.

More News (JNJ)

Johnson & Johnson and UnitedHealth report Q3 results, setting healthcare sector tone for 2027.

Johnson & Johnson and UnitedHealth report Q3 results, setting healthcare sector tone for 2027.

Johnson & Johnson and UnitedHealth Group both released their third-quarter 2026 earnings on the same morning, highlighting key trends in drug costs, insurance margins, and sector outlook. Johnson & Johnson showed steady revenue growth with strong per...

Company Fundamentals
Neutral
5 hours ago
Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growth

Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growth

Johnson & Johnson will report its Q3 2026 earnings on October 13, with analysts expecting earnings per share (EPS) of $2.66, a 5% decline from last year, while revenue is forecasted to grow 5.8% to $25.40 billion. Despite the EPS drop, the company ha...

Company Fundamentals
Neutral
3 days ago
Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.

Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.

Four Dividend Kings—Johnson & Johnson, Procter & Gamble, Coca-Cola, and PepsiCo—continue to deliver steady dividends, crucial for retirees relying on portfolio income. Johnson & Johnson and Procter & Gamble show very safe dividend payouts with health...

Market News
Neutral
3 days ago
New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.

New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.

Johnson & Johnson announced two-year Phase 3 results for ICOTYDE (icotrokinra), an oral peptide targeting IL-23 receptor 1, showing sustained high skin clearance rates in adults and adolescents with moderate-to-severe plaque psoriasis. Nearly 72% of ...

Company Fundamentals
Bullish
3 days ago
Five top U.S. dividend stocks show strong payout records and reliable income for investors.

Five top U.S. dividend stocks show strong payout records and reliable income for investors.

Five major U.S. companies—Coca-Cola, Procter & Gamble, Johnson & Johnson, PepsiCo, and Realty Income—are highlighted for their long histories of dividend increases and strong cash flow coverage. These firms offer diverse dividend yields, with some pr...

Market News
Bullish
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App